Psychological Resilience, Perceived Stress and Periodontal Status Among Bruxers

by palligoelme@gmail.com | Jun 2, 2026 | Clinical Trials

​ Conditions: Periodontitis; Bruxism; Perceived Stress Interventions: Other: Resilience assessment Sponsors: Postgraduate Institute of Dental Sciences Rohtak Not yet recruiting Conditions: Periodontitis; Bruxism; Perceived Stress Interventions: Other: Resilience...

The Effect of Silicone Foam Dressing and Repositioning on the Prevention of Endotracheal Tube-related Pressure Injuries

by palligoelme@gmail.com | Jun 2, 2026 | Clinical Trials

​ Conditions: Pressure Injury Prevention Interventions: Other: Use of silicone foam dressing and repositioning every 8 hours; Other: Repositioning every 8 hours Sponsors: Hacettepe University Not yet recruiting Conditions: Pressure Injury Prevention Interventions:...

The Effects of Somatic-Based Chair Exercises in the Elderly

by palligoelme@gmail.com | Jun 1, 2026 | Clinical Trials

​ Conditions: Elderly (People Aged 65 or More) Interventions: Other: Somatic-Based Chair Exercises; Other: Conventional Exercise Group Sponsors: Istanbul Gedik University; Medipol University Not yet recruiting Conditions: Elderly (People Aged 65 or More)...

RAIRI-Guided Adjuvant Therapy Benefit in Nasopharyngeal Cancer

by palligoelme@gmail.com | Jun 1, 2026 | Clinical Trials

​ Conditions: Nasopharyngeal Cancinoma (NPC) Interventions: Drug: PD-1 inhibitor; Drug: Capecitabine Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Fujian Cancer Hospital; Sun Yat-Sen University Cancer Center; Hunan Cancer Hospital;...

Results of Combined Medical and Swallowing Behavioral Readjustment Therapy in Oropharyngeal Dysphagia Management Among Parkinson’s Patients

by palligoelme@gmail.com | Jun 1, 2026 | Clinical Trials

​ Conditions: Oropharyngeal Dysphagia (OPD); Parkinson; Swallowing Difficulties Interventions: Behavioral: combined pharmaceutical treatment and rehabilitation techniques; Drug: pharmaceutical treatment only Sponsors: Tanta University Completed Conditions:...

Efficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast Cancer

by palligoelme@gmail.com | Jun 1, 2026 | Clinical Trials

​ Conditions: HR+/HER2- Early Breast Cancer Interventions: Drug: Culmerciclib; Drug: Aromatase Inhibitors Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting Conditions: HR+/HER2- Early Breast Cancer Interventions: Drug:...